Hypoxia-inducible factor-1a (HIF-1a) is a principal regulator of angiogenesis and other cellular responses to hypoxic stress in both normal and tumor cells. To identify novel mechanisms that regulate expression of HIF-1a, we designed a genome-wide screen for expressed sequence tags (ESTs) that when transcribed in the antisense direction increase production of the HIF-1a target, vascular endothelial growth factor (VEGF), in human breast cancer cells. We discovered that heat shock factor (HSF) proteins 2 and 4-which previously have been implicated in the control of multiple genes that modulate cell growth and differentiation and protect against effects of environmental and cellular stresses-function together to maintain a steady state level of HIF-1a transcription and VEGF production in these cells. We show both HSFs bind to discontinuous heat shock element (HSE) sequences we identified in the HIF-1a promoter region and that downregulation of either HSF activates transcription of HIF-1a. We further demonstrate that HSF2 and HSF4 displace each other from HSF/HSE complexes in the HIF-1a promoter so that HIF-1a transcription is also activated by overexpression of either HSFs. These results argue that HSF2 and HSF4 regulate transcription of HIF-1a and that a critical balance between these HSF is required to maintain HIF-a expression in a repressed state. Our findings reveal a previously unsuspected role for HSFs in control of VEGF and other genes activated by canonical HIF-1a-mediated signaling.
Introduction
Angiogenesis-the process of formation of new blood vessels-is regulated in both normal tissues and tumors largely by an oxygen-sensitive signaling pathway that involves hypoxia-inducible factor-1 (HIF-1) and vascular endothelial growth factor (VEGF) (Mazure et al., 1996 (Mazure et al., , 1997 Semenza, 2003; Ng et al., 2006; Pouyssegur et al., 2006; Brahimi-Horn and Pouyssegur 2007; Fraisl et al., 2009) . Under normoxic conditions, the steady state level of the a subunit of HIF-1 (HIF-1a) is tightly controlled by prolyl hydroxylation. During hypoxia, hydroxylation and consequent degradation of the HIF1a protein is inhibited and HIF-1a accumulatesinteracting with the b subunit of HIF-1 and binding to specific DNA sequences (hypoxia-response elements; HREs) in the transcription-regulating region of genes that promote cell growth-and activating these genes. Among the genes activated by HIF-1a is VEGF, which together with other HIF-1-regulated genes encoding fibroblast growth factors, glucose transporter 1 and erythropoietin, facilitates the survival and proliferation of O 2 -deprived cells (Semenza, 2003; Pouyssegur et al., 2006; Brahimi-Horn and Pouyssegur, 2007; Fraisl et al., 2009) . Upregulation of HIF-1a expression or blockade of the degradation can also occur under normoxic conditions in cancer cells, contributing to tumor progression (Jiang et al., 1997; Isaacs et al., 2002; Chi and Karliner, 2004; Busca et al., 2005) . Although the regulation of HIF-1a expression at the translational and post-translational levels has been studied extensively (Semenza, 2003; Pouyssegur et al., 2006; Brahimi-Horn and Pouyssegur, 2007; Fraisl et al., 2009) , relatively little is known about mechanisms that affect HIF-1a transcription (Jiang et al., 1997; Page et al., 2002; Busca et al., 2005; Pipinikas et al., 2008; Nardinocchi et al., 2009) .
Our laboratory has developed a function-based strategy that uses antisense RNAs complementary to a collection of lentiviral-based ESTs to randomly inactivate chromosomal genes (Lu et al., 2004) . Using this approach, together with a fluorescence-activated cell sorting (FACS) screen that enables the isolation of cell clones showing elevated VEGF expression (Liliental and Cohen, in preparation), we discovered the previously unsuspected role of heat shock transcription factors (heat shock factors; HSFs) in the regulation of canonical HIF-1a/VEGF signaling. We show that heat shock factors HSF2 and HSF4, which were known previously for their ability to modulate cell growth and differentiation as well as the cellular response to stress (Pirkkala et al., 2001; Chi and Karliner, 2004; Chang et al., 2006; Akerfelt et al., 2007; Morimoto, 2008; Zhang et al., 2008) , function together to maintain the steady state level of HIF-1a mRNA by binding to heat shock element (HSE) sites in the promoter region of the HIF1a gene and regulating HIF-1a transcription.
Results

Upregulation of VEGF expression by HSF4 deficiency
A library of MCF-7G cells infected with a lentiviralbased collection of 40 000 sequenced ESTs under control of a tetracycline-repressed promoter (Lu et al., 2004) was subjected to FACS to isolate clones in which expression of a VEGF gene fusion with a GFP reporter gene protein was increased (Liliental and Cohen, in preparation) . Among these was clone C16, in which cells showed fourfold greater GFP fluorescence than the parental cell line MCF-7G, as determined by FACS analysis (Figure 1a ). DNA sequencing revealed that clone C16 contains a chromosomally inserted EST (GenBank image clone 3395089) corresponding to part of the protein-coding region of heat shock factor 4 (HSF4), a transcriptional regulator previously implicated in expression of heat shock proteins (HSPs)-chaperones that assist protein folding and protect cells against proteotoxic stress (Nakai et al., 1997; Pirkkala et al., 2001; Chi and Karliner, 2004; Min et al., 2004; Fujimoto et al., 2004 Fujimoto et al., , 2008 Akerfelt et al., 2007) . This HSF4 EST was oriented in the antisense direction relative to the lentiviral promoter.
Two alternatively spliced transcripts encoding distinct HSF4 isoforms, HSF4a and HSF4b, which possess different transcriptional activity have been described (Nakai et al., 1997; Pirkkala et al., 2001; Chi and Karliner, 2004; Min et al., 2004; Akerfelt et al., 2007; Fujimoto et al., 2004 Fujimoto et al., , 2008 ; whereas RT-PCR results showed that both HSF4a and HSF4b mRNAs are expressed in MCF-7 cells, only the protein isoform encoded by HSF4a was detected in MCF-7 cells by western blotting. The ability of the HSF4 EST to regulate VEGF expression was shown directly, by use of an MCF-7G-derived cell clone, EK-F4 that contains the HSF4 EST inserted into the chromosome under control, in antisense orientation, of a tetracycline-repressed cytomegalovirus (CMV) promoter (Figures 1b-d) . In the absence of tetracycline repression, the abundance of HSF4 protein in EK-F4 cells was about one fifth the abundance in the parental cell line (Figure 1b) . Similarly, RT-PCR analysis showed that VEFG mRNA was elevated more than threefold ( Figures  1c and d) when the CMV promoter driving antisense transcription of the HSF4 EST was activated. Turndown of antisense transcription of the HSF4 EST by the addition of tetracycline returned VEGF mRNA to normal levels ( Figure 1c ).
Further evidence of the stimulatory effect of HSF4 downregulation on VEGF expression was obtained by introducing an antisense oligodeoxynucleotide (AS-F4) complementary to HSF4, or alternatively, an HSF4-specific double-stranded siRNA (si-F4) into MCF-7 cells. Both events, which decreased HSF4a protein to B40% of normal in a pool of transfected cells, produced a reciprocal increase in VEGF mRNA abundance, as indicated by RT-PCR analysis (Figures  1e-g ). Enzyme-linked immunosorbent assay measurements showed greater accumulation of VEGF protein in the culture media during a 96-h growth period of cells transfected with HSF4 siRNA than in cells similarly transfected with a randomly scrambled siRNA (Figure 1h ). Collectively, these experiments indicate that HSF4 deficiency in MCF-7 cells increases the production of VEGF mRNA and protein.
The effects of HSF4 in VEGF expression are mediated through HIF-1a The production of VEGF is controlled largely by transcription factors that include HIF-1, HIF-2 and SP1 (Jiang et al., 1997; Mazure et al., 1996 Mazure et al., , 1997 Tsuzuki et al., 2000; Bos et al., 2001; Semenza, 2003; Olenyuk et al., 2004; Pouyssegur et al., 2006; Brahimi-Horn and Pouyssegur, 2007; Fraisl et al., 2009) . We observed that a cis-acting mutation known to prevent transcriptional activation by HIF-1a of a luciferase reporter gene linked to an HRE of the VEGF promoter (Mazure et al., 1996 (Mazure et al., , 1997 Tsuzuki et al., 2000; Olenyuk et al., 2004; Pore et al., 2004) abrogated the elevation of luciferase activity otherwise seen during downregulation of HSF4 (Figure 2a ). The implication of this finding, namely that the effects of HSF4 downregulation on VEGF production are mediated through HIF-1a, was confirmed by western blotting (Figure 2b ) and RT-PCR analysis ( Figure 2c) ; these analyses showed that HIF-1a mRNA and protein are both elevated in EK-F4 cells, and that the addition of tetracycline, which turns down antisense transcription of the chromosomally inserted HSF4 EST in these cells, reversed this increase. Consistent with these results, a population of MCF-7 cells transfected with a single-strand DNA oligonucleotide complementary to HSF4 mRNA (AS-F4) or with siRNA directed against HSF4 mRNA (si-F4) also showed elevation of HIF-1a mRNA (Figure 2c ).
HSF2 is also required to maintain repression of HIF-1a transcription The findings presented above indicate that HSF-4 downregulation increases the production of HIF-1a mRNA and protein, implying that HSF4 functions as a repressor of HIF-1a expression. However, during our studies we surprisingly observed that adventitious overexpression of mRNA encoding either HSF4a or HSF4b isoform also resulted in increased HIF-1a expression (Figures 3a and b) -and to the same extent as HSF4 deficiency (cf. Figures 1 and 3 )-suggesting that HSF4 actions on HIF-1a expression are more complex than simple transcriptional repression. Individual HSFs are known to function in concert with, or in opposition to, other members of the HSF family (Mathew et al., 2001; Pirkkala et al., 2001; Chi and Karliner, 2004; Xing et al., 2005; Loison et al., 2006; Akerfelt et al., 2007; Ostling et al., 2007; Sandqvist et al., 2009; Yamamoto et al., 2009) , and we hypothesized that HSF4 may participate with another HSF family member in the regulation of HIF-1a transcription. To investigate this possibility, we tested the effects of downregulation of two other HSF proteins known to be produced in human cells (that is, HSF1 and HSF2) (Fujimoto and Nakai, 2010) . Whereas downregulation of HSF1 had no detectable affect on the HIF-1a expression, siRNA against HSF2 or an antisense oligonucleotide complementary to the HSF2 transcript (AS-F2) resulted in a two to fourfold increase in the steady state level of HIF-1a protein and mRNA, respectively (Figures 4a and b) . These findings, which parallel the HIF-1a expression changes occurring during HSF4 downregulation (Figure 2 ), suggested that HSF2 is required along with HSF4 to maintain steady state repression of HIF-1a transcription. Two alternatively spliced transcripts encoding distinct HSF2 isoforms, HSF2a and HSF2b, possessing different transcriptional activity have been described (Pirkkala et al., 2001) , and RT-PCR results showed that both HSF2a and HSF2b mRNAs are expressed in MCF-7 cells (data not shown). Overproduction from a CMV promoter of either of the two HSF2 isoforms, which are similar in molecular mass and were not resolved by western blotting under the conditions employed (Figure 4c HSF4 and HSF2 bind to HSE-containing loci in the HIF-1a promoter region Earlier work has shown that HSF regulation of gene expression involves the binding of HSFs to doublestrand regions of DNA known as HSEs; HSE sequences, which are highly conserved among a broad range of eukaryotes, consist of multiple inverted repeats of the pentamer nGAAn, or of a variant of this sequence (Somasundaram and Bhat, 2004; Xing et al., 2005; Akerfelt et al., 2008; Fujimoto et al., 2008; Murphy et al., 2008) . Consistent with our evidence that HSF4 and HSF2 are regulators of HIF-1a transcription, Heat shock factor regulation of HIF-1a transcription R Chen et al analysis of the 2-kb DNA region upstream from the HIF-1a transcriptional start site by the Vector NTI motif program revealed two discontinuous regions rich of 'GAA/TTC' repeats. The positions of these loci, À901/À864 (HSE1) and À1463/À1422 (HSE2) are shown in Figure 5a relative to the previously identified site of initiation of HIF-1a transcripts (Human genome BLAT Search/The UCSC Genome Bioinformatics).
Chromatin immunoprecipitation (Ch-IP) assays were performed to determine whether HIF-1a promoter region segments containing putative HSE sequences do, in fact, bind to HSF4 and/or HSF2. In these experiments, complexes immunoprecipitated by anti-HSF4 or HSF2 antibodies were used as substrates for 30 PCR cycles primed by oligonucleotide pairs corresponding to locations bracketing HSE1 (primers P1 and P2) or HSE2 (primers P3 and P4) ( Figure 5a ). As seen in Together, the requirement for both HSF2 and HSF4 for repression of HIF-1a transcription and the finding that overproduction of either protein can also lead to activation of HIF-1a transcription suggested a model in which (a) HSF2 and HSF4 are components of a complex that mediates repression of the HIF-1a promoter, and (b) disruption of the normal stoichiometry of the postulated repression complex interferes with the ability of the complex to repress HIF-1a transcription. Consistent with the above model, we observed, by an additional Ch-IP analysis that overexpression of either HSF2 or HSF4 reduced the amount of the other HSF present in complexes with DNA containing the HSE sites that we identified in the HIF-1a promoter. Transfection of MCF-7 cells (Figure 5c That HSF2 and HSF4 can interact specifically with HSE sequences was shown by electrophoretic mobility shift assays using in vitro synthesized oligonucleotides. The [
32 P]-labeled HSE86 probe contains three perfect nGAAn pentameric units and was previously reported to bind with both HSF2 and HSF4 (Fujimoto et al., 2008) . As seen in Figure 5d Heat shock factor regulation of HIF-1a transcription R Chen et al
Unlabeled synthetic oligonucleotides comprising the HSE1 (lanes 5 and 6) or HSE2 (lanes 7 and 8) sequence of the HIF-1a promoter also partially competed with the shift of the labeled probe, and at higher concentrations totally competed (HSE1, lanes 11 and 12; HSE2, lanes 13 and 14). These results confirm that the specific HIF-1a promoter region sites, which we have identified as discontinuous HSEs interact with both HSFs. HSF2 and HSF4 are expressed in multiple tissues and have biologically diverse functions and tissue-specific functions (Akerfelt et al., 2007; Fujimoto and Nakai, 2010) . The results presented above (Figure 5c ) indicate that HSF interactions with HIF-1a promoter region HSEs also occur in vivo in HeLa cells. We tested the effect of HSF2 and HSF4 knockdown or overexpression on VEGF production in HeLa and 293T cell lines. As shown in Figure 6 , these manipulations resulted in a VEGF increase in both cell types that was similar in magnitude to the increase we had observed in MCF-7 cells, indicating that the effects of HSFs on VEGF production extend beyond the human breast cancer cell line used to discover this role of HSFs.
Discussion
The findings reported here reveal a hitherto unsuspected mechanism of regulation of expression of the canonical HIF-1a/VEGF signaling pathway by HSFs 2 and 4. Our findings indicate that the effects of HSF2 and HSF4 on VEGF expression-and probably also on the expression of other genes controlled by HIF-1a/HRE-mediated signaling-is affected by the relative abundance of HSF4 and HSF2. Previous studies have shown that HIF-1a transcription can be upregulated by non-hypoxic events, as well as by hypoxia-leading to increased expression of VEGF and other HIF-1a targeted genes (Jiang et al., 1997; Page et al., 2002; Busca et al., 2005; Pipinikas et al., 2008; Nardinocchi et al., 2009) . Our results raise the prospect that HSF2/HSF4 complexes at the HSE elements of the HIF-1a promoter, which potentially may vary quantitatively in composition in different types of normal or tumor cells, may be one such mechanism of non-hypoxic regulation.
Transcriptional regulation of HSPs by HSF family members in response to heat, infection and inflammation, Heat shock factor regulation of HIF-1a transcription R Chen et al and to exposure to pharmacological agents and other stresses is a process that is evolutionarily conserved in eukaryotic cells (Pirkkala et al., 2001; Chi and Karliner, 2004) . In addition to containing a highly conserved DNA-binding domain, HSFs all include hydrophobic regions that mediate the formation of dimers or trimers (Yamamoto et al., 2009; Fujimoto and Nakai, 2010) . In mammalian cells, HSF1 is the major factor controlling stress-inducible HSP expression, whereas HSF4 and HSF2 have been reported to be more selective transcriptional regulators that do not control expression of classical HSPs (Nakai et al., 1997; Mathew et al., 2001; Zhang et al., 2001; Loison et al., 2006 for recent review, see Fujimoto and Nakai, 2010) . Notwithstanding their common structural features, their ability to form homotrimers (Yamamoto et al., 2009) , and the functionally important interactions that occur between HSF2 and HSF4 at the HSEs of the HIF-1a promoter region, HSFs that are not bound to HSEs have not been observed in earlier work to interact with each other Heat shock factor regulation of HIF-1a transcription R Chen et al (Mazure et al., 1997; Tsuzuki et al., 2000; Pirkkala et al., 2001; Fujimoto et al., 2004; Min et al., 2004) ; similarly, interaction between unbound HSFs was not detected by us in co-immunoprecipitation experiments (data not shown). Our evidence that HSF2 and HSF4 can regulate transcription of HIF-1a together with our discovery of discontinuous HSE-like sequences in the HIF-1a promoter region suggested that these HSFs would bind to the sites identified by sequence analysis as possible HSEs. Results from our Ch-IP and electrophoretic mobility shift assays confirmed the role of these sites as HSEs. Whereas HSF1, which is the major stressactivated regulator, binds to continuous HSEs, both HSF2 and HSF4 bind preferentially to discontinuous HSEs. Our findings are also consistent with previous evidence that different HSFs can have targets in common (Akerfelt et al., 2008; Fujimoto et al., 2008; Yamamoto et al., 2009) . Whereas the DNA-binding domains of the three HSFs identified in mammalian cells are highly similar (70.5% identity between HSF1 and HSF2, 76.2% identity between HSF1 and HSF4 and 62.4% identity between HSF2 and HSF4), HSFs nevertheless show different DNA-binding preferences (Somasundaram and Bhat, 2004; Fujimoto et al., 2004 Fujimoto et al., , 2008 Yamamoto et al., 2009) . Potentially, such preferences may have a role in determining the effects of HSF/HRE complexes in the HIF-1a promoter region.
Our data show that HSF2 and HSF4 can each interact with both HSEs in the HIF-1a promoter and both are required to maintain steady state repression of HIF-1a transcription. They also show that overexpression of either HSF2 or HSF4 reduced the presence of the other HSF at each of the HIF-1a HSEs and additionally resulted in activation of HIF-1a transcription. The binding of HSF4 to discontinuous HSEs has been shown to be dependent on trimerization of this HSF (Yamamoto et al., 2009) , and-as noted earlierindividual members of the HSF's family can function in concert with, or in opposition to other HSF family members. These considerations, together with our finding that disruption of the balance between the amounts of HSF2 and HSF4 abrogates steady state repression of HIF-1a transcription, lead us to speculate that the transcription-limiting interactions between HSF2 and HSF4 at HSE elements may involve heteromultimer formation. While this notion is consistent with both the observations reported here and with previous knowledge about HSF binding to HSEs, structural analysis of HSF/HSE complexes will be required for confirmation.
Given the cell-type specificity of HSF actions (Fujimoto and Nakai, 2010) it seems likely that the effects of HSFs on HIF-1a transcription observed in human breast cancer cells may differ in other cell types and may also be affected differently by heat shock and other stress conditions in different cell types (see Mathew et al., 2001; Pirkkala et al., 2001; Chi and Karliner, 2004; Xing et al., 2005; Loison et al., 2006; Akerfelt et al., 2007 Akerfelt et al., , 2008 Ostling et al., 2007; Sandqvist et al., 2009; Yamamoto et al., 2009 ). However, notwithstanding these considerations, our data show that the effects of HSF2 and HSF4 on VEGF production in at least two other cell lines-HeLa and 293T cells-are similar to those seen in MCF-7 cells. A preliminary screen of the effects of physiological stresses has not identified stress conditions that regulate HIF-1a production in an HSF-dependent manner in the cell lines we have investigated.
Earlier work has shown that the HSP90 (Fujimoto et al., 2004; Min et al., 2004) , which is a target of transcriptional control by HSF4 is required for HIF-1a-mediated VEGF expression (Minet et al., 1999; Isaacs et al., 2002) . Additionally, expression of another HSF4-modulated heat shock protein, HSP27 (Fujimoto et al., 2004; Min et al., 2004) , is correlated with tumor-induced angiogenesis (Wartenberg et al., 2001) . Whereas it was tempting to suspect a role for HSP90 or HSP27 in the increased VEGF production we observed during downregulation of HSF4 or HSF2, real-time PCR and western blot experiments failed to detect any effect of HSF2 or HSF4 siRNA on the production of HSP90 protein in MCF-7 cells during a 24-h period after transfection of these siRNAs (data not shown). While HSF4 siRNA transfection did produce a decrease in HSP27 expression at both the mRNA and protein levels under the same experimental conditions, restoration of HSP27 expression during HSF4 downregulation in MCF-7 cells did not prevent upregulation of HIF-1a transcription-indicating that the derepression of HIF1a transcription in these cells was not a consequence of deficient HSP27 expression (data not shown). However, our results do not exclude the possibility that HSFinduced changes in HSP expression can supplement the regulatory mechanisms reported here.
Materials and methods
Cell culture, pVEGF-EGFP integrated MCF-7 cells MCF-7 cells (estrogen receptor-positive and progesterone receptor-positive; American Type Culture Collection, Manassas, Heat shock factor regulation of HIF-1a transcription R Chen et al VA, USA) were used in all of the experiments. The MCF-7 line containing the tet-off transactivator tTA was established as described previously (Lu et al., 2004) . The VEGF 2.8 kbpromoter controlled EGFP expression vector pVEGF-EGFP (Fukumura et al., 1998 ) is a kind gift from Dr B Seed (Massachusetts General Hospital). We substituted the puromycin resistance marker into the hygromycin resistance marker. pVEGF-GFP was transfected into MCF-7 cells and the stably transfected cells were selected by adding hygromycin 200 mg/ml 40 h after the start of transfection. We cultured the MCF-7 cells and pVEGF-EGFP integrated MCF-7 cells in DMEM (Invitrogen, Carlsbad, CA, USA) containing 10% FBS.
Lentivirus production and infection
We produced lentivirus by transient transfection of 293T cells (calcium phosphate precipitation method) by using library DNA along with DNAs of packaging and VSVG envelope constructs as described previously (Lu et al., 2004) .
Fluorescence-activated cell sorting
We established the EST-based genome-wide gene inactivation library of pVEGF-EGFP MCF-7 cells and utilized FACS to screen and isolate pVEGF-EGFP MCF-7 clones in which GFP-fluorescent signals were increased. FACS was done in the Stanford Shared FACS Facility.
Identification of EST clones
Genomic DNA was isolated from individual clones and the EST insertion was identified by PCR and DNA sequencing as described previously (Lu et al., 2004) .
Treatment of cells with antisense oligos and siRNAs
Phosphorothioate antisense (AS) oligos used in this study were synthesized from the Stanford PAN Facility. The sequence of HSF4 AS oligo is 5 0 -AGAGGCTGTAAGTAGAAGGC, the sequence of HSF2 AS oligo is 5 0 -TGGGTTTCCTCCACA AGCGT and the sequence of HSF1 AS oligo is 5 0 -GGTCGAA CACGTGGAAGCTG. siRNAs were purchased from Dharmacon (Lafayette, CO, USA). The sequence of HSF4 siRNA is 5 0 -GAGACAAAUUUGGGCCUUAUU (sense), the sequence of HSF2 siRNA is 5 0 -UAUCGACUCUGGAAUU GUAUU (sense) and the sequence of HSF1 siRNA is 5 0 -CCACUUGGAUGCUAUGGAC. A scrambled siRNA duplex (5 0 -CAGCGCUGACAACAGUUUCAU) was used as a control.
MCF-7 cells plated at the density of 4000 cells per 1.9 cm 2 were treated 1 day later for 1 or 2 days with AS oligo or siRNA, respectively. Effectene (Qiagen, Valencia, CA, USA) and Lipofectamine2000 (Invitrogen), were used to increase the AS oligo or siRNA uptake into the cells. The cells were treated with 0.8 mM AS oligo or 0.1 mM siRNA after a pre-incubation for 20 min with 3 mg/ml Effectene or Lipofectamine2000 in serum-free OPTI-MEM (Invitrogen). After 4 h, the medium was replaced with standard culture medium as described above. For the AS oligo experiments, cells were harvested after another 4 h incubation. For siRNA experiments, cells were harvested after 32 h incubation.
RNA isolation and reverse transcription
Total RNA was prepared from harvested cells with the RNeasy Midi Kit (Qiagen) and treated with RNase-free DNase (Qiagen) according to the manufacturer's instructions. The SuperScript II (Invitrogen) reagent set was used for reverse transcription reaction, which was carried out using standard protocol provided by the manufacturer. The reverse transcription reaction was performed at 42 1C for 50 min and was stopped by heating up to 70 1C for 15 min.
Semi-quantitative PCR and real-time quantitative PCR
The reverse transcription and real-time PCR primers were designed to span introns by using Vector NTI 9 (Invitrogen). GUSB (b-glucuronidase) mRNA is amplified as the control. The specific primers sequences are HIF-1a 5
0 -GTCTCACGAG GGGTTTCCCG-3 0 (forward) and 5 0 -GCCGAGATCTGGCT GCATCT-3 0 (reverse); VEGF 5 0 -TGCACCCATGGCAGAA GGAG-3 0 (forward) and 5 0 -TGTGCTGGCCTTGGTGAGGT (reverse); GUSB 5 0 -CGGCCTGTGACCTTTGTGAG-3 0 (forward) and 5 0 -ATTCCCCAGCACTCTCGTCG-3 0 (reverse). Real-time PCR was performed by using Bio-Rad iQ SYBR Green Supermix (to 1 Â ), 250 nM each PCR primer in 20 ml and a Bio-Rad fluorescent real-time PCR instrument. The reaction started with 3 min of pre-incubation at 95 1C followed by 40 amplification cycles. The threshold cycle (Ct) was determined by use of the maximum-second-derivative function of the software. Formation of expected PCR product was confirmed by agarose gel electrophoresis (2%) and melting curve analysis.
Transfection and assays for luciferase and b-galactosidase A 1.4-kb wild-type VEGF-promoter-driven luciferase construct and an HRE-mutated VEGF-promoter-driven luciferase construct (Pore et al., 2004) , are kind gifts from Dr A Maity (University of Pennsylvania School of Medicine, Philadelphia, PA, USA). A 5-HRE-driven luciferase construct is a kind gift from Dr Giaccia (Cancer Biology Research Laboratory, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA). For promoter activity analysis, transient transfection was carried out using Lipofectamine2000 (Invitrogen). Unless specified in the figure legends, the cells were plated in 24-well tissue culture plates at 4 Â 10 4 /well and cultured for 18 h before being transfected with 0.1 mg/well of VEGF/HRE promoter luciferase reporter construct. As the control for transfection efficiency 0.1 mg/well of pCMV-b-Gal expression vector was simultaneously transfected. For co-expression assays, a total 0.02À0.2 mg/well of expression vector for transcription factors were used, empty pcDNA3 is used as the control. The cells were harvested 36 h after transfection, and the luciferase activity and b-galactosidase expression levels were assayed according to the manufacturer's protocols (Promega, Sunnyvale, CA, USA). The promoter activities were normalized in relative light units/ milliunit of b-galactosidase activity.
The pcDNA3-HSF4 expressing plasmid (Zhang et al., 2001 ) was kindly offered by Dr NF Mivechi (Medical College of Georgia, Augusta, GA, USA). The pcDNA3-HSP27 expressing plasmid (Schafer et al., 1999) was kindly offered by Dr R Benndorf (University of Michigan, Ann Arbor, MI, USA).
Western blotting
Unless specified in the figure legends, the cells were plated in 6-well tissue culture plates at 2 Â 10 5 /well and cultured for 18 h before being used. For overexpression assay, a total 0.8 mg/well of expression vector for transcription factors were used, blank pcDNA3 was used as the control. We prepared the nuclear or whole cell extracts and performed the western blot analysis by using a standard protocol. Antibodies were used at 1:1000 dilution for the polyclonal rabbit anti-HSF4b antibody (a kind gift from Dr SP Bhat, University of California, Los Angeles, CA, USA), 1:1000 for the monoclonal mouse anti-HSF4a (BD Biosciences, San Jose, CA, USA), 1:250 for the monoclonal mouse anti-HIF-1a (BD Biosciences), 1:1000 for the polyclonal rabbit anti-HSP90 (Cell Signaling Technology, Beverly, MA, USA), 1:1000 for the monoclonal mouse anti-HSP27 (Cell Signaling Technology), 1:250 for the monoclonal rat anti-HSF2 (Millipore, Billerica, MA, USA) and 1:5000 for the monoclonal mouse anti-a-tubulin (Sigma-Aldrich, St Louis, MO, USA). Antigen-antibody complexes were detected by chemiluminescence (Western Lightning, GE Healthcare, Piscataway, NJ, USA). Density of the bands was analyzed using ImageJ software 1.41b (Image Processing and Analysis in Java, National Institutes of Health, Bethesda, MD, USA). The results are expressed as a protein/a-tubulin density ratio.
Chromatin immunoprecipitation
Non-stimulated MCF-7 cells, MCF-7 cells transfected with HSF4 or HSF2 siRNAs, and MCF-7 cells transfected with pcDNA3-HSF4 were treated with 10% formaldehyde for 10 min at 37 1C. Then the cells were washed twice with ice-cold PBS and suspended in the lysis buffer (0.5% NP-40, 150 mM NaCl, 50 mM Tris pH 7.5, w/protease inhibitors). After 10 min incubation on ice, cells were centrifuged to pellet the nuclei. Nuclei were then suspended in the nuclei lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris pH 8.1, w/protease inhibitors), incubated on ice for 10 min and sonicated for 1.5 min (30 s each time, then cooled on ice and repeated twice). The sheared chromatin was then immunoprecipitated by using a specific monoclonal anti-HSF2 antibody or a specific monoclonal anti-HSF4 antibody. After extensive washing and then elution, the crosslink was reverted by heat treatment (65 1C overnight and protease K digestion). The captured genomic DNA fragments were then purified by using Qiagen PCR purification kit. Identification of the captured HIF-1a promoter fragments was performed by PCR analysis by using the promoter primers. The sequences of primers covering region À915 to À658, are 5 0 -ACTCTTTGCCACGGAGCACA (forward) and 5 0 -GCT TGCAAAGTTGCCAAAGG (reverse); the sequences of primers covering region À1455 to À995, are 5 0 -TTGAGCCCA ACAAAGTAGCATT (forward), 5 0 -CTTCTCTTCAGGCA TTTCCCA (reverse). Thirty cycles of PCR were performed and the amplified products were analyzed on a 2% agarose gel.
Gel mobility shift assays Gel mobility shift assays were performed as described previously (Fujimoto et al., 2008) . Briefly, nuclear extracts (B20-30 mg of protein) and B20-30 fmol of 32 P-labeled double-stranded HSE86 oligonucleotide ([ 32 P]HSE86) were used in a typical assay. The sequence of the forward strand is 5 0 -ggGAgggGAAaaTTCgaGAAgaagtga-3 0 . Competitive binding is done by adding unlabeled double-stranded oligonucleotides HSE1 or HSE2 to the reaction. The sequences of the forward strands of HSE1 and HSE2 are 5 0 -aaggccattttTTCtactctTTCcctGAAattggtt-3 0 and 5 0 -ttcTTCtcTTCag GcAttTcCcatggTTCttTTCaag-3 0 , respectively. The sequences in capital letters denote the pentameric, GAA/TTC motifs. The reactions were carried out at room temperature for 20 min. The entire volume of the reaction was electrophoresed on 4% acrylamide gel in a buffer containing 50 mM Tris, pH 7.9, 40 mM glycine and 1 mM EDTA. The gels were run at 150 V for B180 min. Under these conditions, no free (unbound) probe is retained in the gel. Complexes were detected by autoradiography. The oligonucleotide probes were endlabeled with polynucleotide kinase (New England BioLabs Inc Beverly MA, USA) using [g-32 P]ATP (Perkin-Elmer, Fremont, CA, USA) according to the manufacturer's protocol. The labeled oligonucleotides were annealed to the unlabeled complementary sequences in equimolar quantities, and double-stranded probes were used for gel shift.
Assay of VEGF protein levels by enzyme-linked immunosorbent assay VEGF protein in conditioned media was assayed using a sandwich ELISA kit (Invitrogen, Camarillo, CA, USA), following the manufacturer's protocol. This assay detects human VEGF in the range of 5-1500 pg/ml. Samples with VEGF concentrations greater than this range were diluted with RPMI Media 640 (Invitrogen, Carlsbad, CA, USA) and reassayed. All samples were assayed in duplicate. Results are presented as mean values ± s.d.
Other reagents and treatments
Desferrioxamine, MG132, novabiocin and tetracycline were purchased from Sigma-Aldrich. The dosage and time course are indicated in the figure legend.
Data analysis
Each experiment was performed independently three times. Thus, experiments presented in the figures are representative of three or more different repetitions. Statistical analysis was performed by using Microsoft Excel 2003.
